Sign in

CIK 0001437402

  • Large accelerated filer

ARDELYX, INC.

Sign in to watch
Ticker
ARDX
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
Phone
+1 510-745-7047
Business address
34175 ARDENWOOD BLVD., FREMONT, CA, 94555
Former names
NTERYX INC
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$486,197
in 8 filings

Net −$486,197. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Reading 100 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2024-01-16 Rosenbaum David P. Chief Development Officer Grant or award +112,750 399,346
2024-01-16 Rosenbaum David P. Chief Development Officer Grant or award +70,120 183,413
2024-01-16 Rosenbaum David P. Chief Development Officer Grant or award · Stock Option (Right to Buy) +145,000 145,000
2024-01-16 Rosenbaum David P. Chief Development Officer Grant or award · Stock Option (Right to Buy) +99,000 99,000
2024-01-16 Rodriguez Susan Chief Commercial Officer Grant or award +112,750 459,723
2024-01-16 Rodriguez Susan Chief Commercial Officer Grant or award · Stock Option (Right to Buy) +145,000 145,000
2024-01-16 Renz Justin A Chief Financial Officer Grant or award +127,750 310,176
2024-01-16 Renz Justin A Chief Financial Officer Grant or award · Stock Option (Right to Buy) +164,000 164,000
2024-01-16 RAAB MICHAEL President & CEO Grant or award +475,000 1,342,868
2024-01-16 RAAB MICHAEL President & CEO Grant or award · Stock Option (Right to Buy) +605,904 605,904
2024-01-16 GRAMMER ELIZABETH A Grant or award +127,750 403,425
2024-01-16 GRAMMER ELIZABETH A Grant or award · Stock Option (Right to Buy) +164,000 164,000
2024-01-16 Felsch Robert Ora Grant or award +70,120 187,186
2024-01-16 Felsch Robert Ora Grant or award · Stock Option (Right to Buy) +99,000 99,000
2024-01-16 Blanks Robert Grant or award +112,750 373,203
2024-01-16 Blanks Robert Grant or award · Stock Option (Right to Buy) +145,000 145,000
2024-01-08 Rosenbaum David P. Chief Development Officer Sale 10b5-1 −30,000 $6.64 $199K 286,596
2023-12-26 Renz Justin A Chief Financial Officer Exercise or conversion 10b5-1 +75,000 $0.99 $74K 407,426
2023-12-26 Renz Justin A Chief Financial Officer Sale 10b5-1 −225,000 $6.36 $1.4M 182,426
2023-12-26 Renz Justin A Chief Financial Officer Exercise or conversion · Stock Option (Right to Buy) 10b5-1 −75,000 121,000

Page 17 of 18 · 360 trades